Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Illuminate Residual Breast Cancer Post-Lumpectomy
.
Show all posts
Showing posts with label
Illuminate Residual Breast Cancer Post-Lumpectomy
.
Show all posts
Wednesday, October 2, 2024
FDA Approves Lumisight (pegulicianine) Optical Imaging Agent to Illuminate Residual Breast Cancer Post-Lumpectomy
›
Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue dete...
›
Home
View web version
